Seven sectors, each read on its own ladder.

57,350 cited records and 11,132 organisations across materials, space, defence, robotics, quantum, fusion and biotech. These sectors have no queue, no COD and no MW, so each gets a gate ladder built from the documents that actually mark its progress — resource reports and strategic status for a mine, contracts and licences for a launch company, grants and raises for fusion, trial phases and clearances for a therapy. The same organisations recur across sectors and into the infrastructure record; that cross-sector read is on every page.

Material supply chains

Critical-mineral deposits, strategic projects, technical reports, smelters and refiners — mine to refiner to cell and magnet maker.

22,903records964organisations$3.3bnon record

R&D awardResource definedStrategic statusPermittedFinancedOfftake signedIn production

Space & aerospace

Launch, spacecraft, satellite and in-space programmes read from R&D awards, prime contracts and air-permitted plants.

1,096records1,063organisations$25.9bnon record

R&D awardContract awardedLaunch or spectrum licenceFacility on recordDelivering

Defence technologies

EDF research and development actions, USASpending and AusTender contracts, TED and Contracts Finder awards.

10,007records1,152organisations$48.1bnon record

R&D awardContract awardedProgramme of recordFacility on recordExport approved

Advanced robotics

Robotic device clearances, robotics and automation contracts, R&D awards, establishment registrations.

1,826records837organisations$1.3bnon record

R&D awardDevice clearanceContract awardedFacility registeredShipping

Quantum technologies

Quantum computing, sensing and networking grants and contracts, public procurement of systems, private placements — and the cloud, error-mitigation, cryo-electronics and PQC build-outs.

3,318records2,269organisations$43.7bnon record

R&D awardContract awardedCapital raisedFacility on recordSystem deployed

Fusion & advanced nuclear

Fusion and advanced-reactor grants, capital raises, HTS magnet and HALEU supply chains, SMR module plants, test facilities — and, where a feed exists, licences.

1,522records446organisations$8.4bnon record

R&D awardCapital raisedRegulatory licenceSite consentedUnder construction

Biotech & life sciences

Industry-sponsored Phase 2/3 trials, NIH awards, 510(k) clearances and registered establishments — and the viral-vector, mRNA, cold-chain, cGMP and sequencing capacity the pipeline needs.

16,678records5,945organisations$66.6bnon record

R&D awardPhase 2 trialPhase 3 trialClearance / approvalFacility registered